The FANTOM Doctoral Network (DN) comprises of 7 beneficiaries and 12 associated partners in 5 EU countries, recruiting 10 researchers and will be embedded into an  established international research programme: The European Research Initiative on Anaplastic Lymphoma Kinase (ALK)-related malignancies (ERIA) and a clinical network: The European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL).

The primary goal of the network is to train the recruited fellows by participation in this internationally competitive research programme and address the clinical problems posed by Anaplastic Large Cell Lymphoma (ALCL) typified by aberrant ALK expression.

The research and training activities will incorporate not only academic labs but also key research institutes, biotechnology companies, clinical trial bodies and Pharma to realise our research goals.